LOVFFCannara Biotech Inc.

About Cannara Biotech Inc. (LOVFF)

Cannara Biotech Inc. (LOVFF) is a Drug Manufacturers - Specialty & Generic company headquartered in Ville St. Laurent, QC, Canada whose shares trade over-the-counter on the OTCQB tier.

Cannara is currently listed and publicly traded on the TSX Venture Exchange ("TSXV") under the symbol "LOVE.V", the OTCQB under the symbol "LOVFF" and the Frankfurt Stock Exchange under the symbol "8CB". Cannara Biotech Inc. is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for the Quebec and Canadian markets. The Company's main focus is to deliver premium quality "AAAA" products at disruptive retail pricing. Leveraging the province's low electricity costs, Cannara owns and operates two Quebec-based facilities spanning over 1,650,000 square feet. Cannara's first purpose-built, modern indoor cultivation facility is located in Farnham, Quebec, and measures 625,000 square feet, comprising 170,000 square feet of operational licensed area and 455,000 square feet of leased warehouse space ("Farnham Facility"). The second facility is a former massive purpose-built cannabis hybrid greenhouse that is being redesigned into an indoor facility zone by zone to ensure consistent and premium flower cultivation. The second facility is over a million square feet in size comprised of 24 independent growing zones totaling 600,000 square feet, a 225,000 square feet cannabis 2.0 processing center and a 200,000 square feet rooftop greenhouse located in Valleyfield, Quebec ("Valleyfield Facility").

Products and services

Cannara Biotech Inc. is a vertically integrated producer of premium‐grade cannabis and cannabis‐derivative products for the Quebec and Canadian markets.

LOVFF key facts

Ticker symbol

LOVFF

Market tier

OTCQB

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Ville St. Laurent, QC, Canada

Country of incorporation

CA

Year of incorporation

2019

Employees

461

Estimated market cap

$77.40M (as of Apr 10, 2025)

Shares outstanding

91,433,135

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

8/31

Latest filing

Interim Financial Report (Nov 30, 2024)

Cannara Biotech Inc. leadership

• Zohar Krivorot — CEO
• Nicholas Sosiak — CFO
• Noemi Follain — VP, Fin. & Acct.

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · OTCQB stocks · OTC stocks starting with L